Motility News

AbbVie announced that it has submitted a supplemental new drug application for Linzess for the treatment of functional constipation in patients aged 6 to 17 years, according to a press release.

Low bacterial diversity and Bifidobacterium depletion were associated with severely symptomatic COVID-19 infection in a small subset of patients — a pattern of dysbiosis that may serve as a susceptibility marker for symptomatic severity.

Disorders of gut-brain interaction cause symptoms throughout the digestive tract including pain, changes in bowel patterns, nausea, regurgitation or vomiting, which can be upsetting or embarrassing for children and teens

Shineco Inc. announced it has been granted a United States Patent and Trademark Office patent and FDA marketing approval for its in-situ fecal specimen sampling device intended for stool test sample collection..

CHARLOTTE, N.C. — Daily treatment with Xifaxan over 2 weeks improved stool consistency and fecal urgency in adults with irritable bowel syndrome-diarrhea, according to a poster at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Once daily plecanatide decreased symptom severity among patients with irritable bowel syndrome-constipation and severe abdominal pain and bloating, according to a poster presented at the ACG Annual Scientific Meeting.

FDA granted fast track designation to Palisade Bio’s broad-spectrum serine protease inhibitor, LB1148, for expedited return of bowel function following gastrointestinal surgery, according to a manufacturer release.

Gastroesophageal reflux disease affects 1 in 5 people in the United States.; although common, the disease is often unrecognized and misunderstood, the International Foundation for Gastrointestinal Disorders reported.

CHARLOTTE, N.C. — An orally ingested vibrating capsule was found to be safe, well tolerated and easy to use for the treatment of chronic idiopathic constipation, according to data presented at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — In a Healio video exclusive, Eamonn Quigley, MD, reported increased compliance to an orally ingested vibrating capsule predicted positive outcomes among patients with chronic idiopathic constipation.